1.
Blauvelt A, Wollenberg A, Pink A, Peris K, Armstrong A, Spelman L, Saeki H, Lynde C, Herranz P, Barbarot S, Simpson E. Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2). J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.11];5(6):s57. Available from: https://jofskin.org/index.php/skin/article/view/1408